Treatment of large vessel vasculitis;Tratamiento de las vasculitis de grandes vasos

Reumatologia Clinica

Volumn 7, Issue SUPPL. 3, 2011, Pages

  Álvarez Hernández, Everardo ^a  

^a UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

Author keywords

Giant cell arteritis; Takayasu's arteritis; Temporal arteritis; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

AORTA ARCH SYNDROME; ARTERITIS; ARTERY DIAMETER; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED CLINICAL TRIAL (TOPIC); CORTICOSTEROID THERAPY; DECISION MAKING; GIANT CELLS ARTERITIS; HUMAN; PHYSICIAN; REMISSION;

ANTI-INFLAMMATORY AGENTS; ARTERITIS; BIOLOGICAL THERAPY; BLOOD VESSEL PROSTHESIS IMPLANTATION; BONE DENSITY CONSERVATION AGENTS; COMBINED MODALITY THERAPY; DRUG THERAPY, COMBINATION; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OSTEOPOROSIS; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TAKAYASU ARTERITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 83255176728     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2011.10.004     Document Type: Article

References (40)

1. Maksimowicz-McKinnon K., Clark T.M., Hoffman G.S. Takayasu arteritis and Giant cell arteritis. A spectrum within the same disease?. Medicine 2009, 88:221-226.
2. Kerr G. Takayasu's Arteritis. Curr Opin Rheumatol 1994, 6:32-38.
3. Maksimowicz-McKinnon K., Clark T.M., Hoffman G.S. Limitations of therapy and guarded prognosis in an American cohort of Takayasu Arteritis patients. Arthritis Rheum 2007, 56:1000-1009.
4. Soto M.E., Espinola N., Flores-Suarez L.F., Reyes P.A. Takayasu arteritis: clinical features in 110 Mexican mestizo patients and cardiovascular impact in survival and prognosis. Clin Exp Rheumatol 2008, 26(Suppl 49):S9-S15.
5. Borg F.A., Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol 2009, 23:325-337.
6. Kerr G.S., Hallahan C.W., Giordano J., Leavitt R.Y., Fauci A.S., Rottem M., et al. Takayasu Arteritis. Ann Int Med 1994, 120:919-929.
7. Vanoli M., Daina E., Salvarani C., Sabbadini M.G., Rossi C., Bacchiani G., et al. Takayasu's Arteritis: A study of 104 Italian patients. Arthritis Car Res 2005, 53:100-107.
8. Jain S., Kumari S., Ganguly N.K., Sharma B.K. Current status of Takayasu arteritis in India. Int J Cardiol 1996, 54(Suppl 2):S111-S116.
9. Ishikawa K., Maetani S. Long-term outcome for 120 japanese patients with Takayasu's disease: clinical and statistical analyses of related prognostic factors. Circulation 1994, 90:1855-1860.
10. Bicakcigil M., Aksu K., Kamali S., Ozbalkan Z., Ates A., Karadag O., et al. Takayasu's arteritis in Turkey - clinical and angiographic features of 248 patients. Clin Exp Rheumatol 2009, 27(Suppl 52):S59-S64.
11. Mwipatayi B.P., Jeffery P.C., Beningfield S.J., Matley P.J., Naidoo N.G., Kalla A.A., et al. Takayasu arteritis: Clinical features and management: report of 272 cases. ANZ J Surg 2005, 75:110-117.
12. Duarte B.P.M., Stambovsky S.E., Cordeiro D.R.L., Oliveira F., Buchatsky D., Porto C., et al. Takayasu's arteritis: Clinical and therapeutic aspects in 36 patients. J Vasc Bras 2007, 7:123-130.
13. Karageorgaki Z.T., Bertsias G.K., Mavragani C.P., Kritikos H.D., Spyropoulou-Vlachou M., Drosos A.A., et al. Takayasu arteritis: epidemiological, clinical and immunogenetic features in Grece. Clin Exp Rheumatol 2009, 27(Suppl 52):S33-S39.
14. Petrovic-Rackov L., Pejnovic N., Jevtic M., Damjanov N. Longitudinal study of 16 patients with Takayasuós arteritis: clinical features and therapeutic management. Clin Rheumatol 2009, 28:178-185.
15. Park M.C., Lee S.W., Park Y.B., Chung N.S., Lee S.K. Clinical characteristics and outcomes of Takayasuós arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment and angiographic classification. Scand J Rheumatol 2005, 34:284-292.
16. Kissin E.Y., Merkel P.A. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol 2003, 16:31-37.
17. Stone J.H. Vasculitis: A Collection of pearls and myths. Rheum Dis Clin North Am 2007, 33:691-739.
18. Hoffman G.S., Ahmed A.E. Surrogate markers of disease activity in patients with Takayasu's Arteritis: a preliminary report from the International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998, 66(Suppl 1):S191-S194.
19. Mukhtyar C., Guillevin L., Cid M.C., Dasgupta B., De Groot K., Groos W., et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009, 68:318-323.
20. Chan M., Luqmani R. Pharmacoterapy of vasculitis. Expert Opin Pharmacoter 2009, 10:1273-1289.
21. Proven A., Gabriel S.E. Glucocorticoid therapy in GCA: duration and adverse outcomes. Arthritis Rheum 2003, 49:703-708.
22. Chevalet P., Barrer J.H., Pottier P., Magadour-Joly G., Pottier M.A., Hamidou M., et al. A randomized multicenter controlled trial using IV pulses of methylprednisolone in the initial treatment of simple forms of GCA: a one year follow up study of 164 patients. J Rheumatol 2000, 27:1484-1491.
23. Mazlumzadeh M., Hunder G.G., Easley K.A., Calamia K.T. Treatment of giant cell arteritis using induction therapy with high dose glucocorticosteroids: a double blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 2006, 54:3310-3318.
24. Hunder G.G., Sheps S.G., Allen G.L., Joyce J.W. Daily and alternate day corticosteroid regimens in treatment of GCA: comparison in a prospective study. Ann Intern Med 1975, 82:613-618.
25. Nesher G., Berkum Y., Mates M., Baras M., Rubinow A., Sonneblick M., et al. Low dose of aspirin and prevention of cranial ischemic complications in GCA. Arthritis Rheum 2004, 50:1332-1337.
26. Mahr A.D., Jover J.A., Spiera R.F., Hernández-García C., Fernandez-Gutierrez B., Lavalley M.P., et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 2007, 56:2789-2797.
27. De Silva M., Hazleman B.L. Azathioprine in GCA- A double blind study. Ann Rheum Dis 1986, 45:136-138.
28. Hoffman G.S., Cid M.C., Rendt-Zagar K.E., Merkel P.A., Weyand C.M., Stone J.H., et al. Infliximab for maintenance of glucocorticoid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 2007, 146:621-630. Infliximab-GCA Study Group.
29. Martínez-Taboada V.M., Rodriguez-Valverde V., Carreño L., Lopez-Longo J., Figueroa M., Belzunegui J., et al. A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticoisteroid side effects. Ann Rheum Dis 2008, 67:625-630.
30. Liang P., Hoffman G.S. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 2004, 17:16-24.
31. Chung S.A., Seo P. Advances in the use of biologic agents for the treatment of systemic vasculitis. Curr Opin Rheumatol 2009, 21:3-9.
32. Molloy E.S., Langford C.A., Clark T.M., Gota C.E., Hoffman G.S. Anti-tumor necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008, 67:1567-1569.
33. Ogino H., Matsuda H., Minatoya K., Sasaki H., Tanaka H., Matsumura Y., et al. Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 2008, 118:2738-2747.
34. Min P.-K., Park S., Jung J.-H., Ko Y.-G., Choi D., Jang Y., et al. Endovascular theraphy combined with immunosuppressive treatment for occlusive arterial disease in patients with Takayasu's arteritis. J Endovasc Ther 2005, 12:28-34.
35. Sharma B.K., Jain S., Bali H.K., Jain A., Kumari S. A follow-up study of ballon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 2000, 75:S147-S152.
36. Miyata T., Sato O., Koyama H., Shigematsu H., Tada Y. Long-term survival after surgical treatment of patients with Takayasu's Arteritis. Circulation 2003, 108:1474-1480.
37. Ioscovich A., Gislason R., Fadeev A., Grisaru-Granovsky S., Halpern S. Peripartum anesthetic management of patients with Takayasu's arteritis: case series and review. Int J Obstet Anesth 2009, 17:358-364.
38. Neunninghoff D.M., Hunder G.G., Christianson T.J., McCleland R.L., Matteson E.L. Mortality of large-artery complications (aortic aneurysm, aortic dissection and/or large-artery stenosis) in patients with giant cell arteritis. Arthritis Rheum 2003, 48:3532-3537.
39. Phillip R., Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008, 26(Suppl 51):S94-S104.
40. Ishikawa K., Maetani S. Long-term outcome for 120 Japanese patients with Takayasu disease: clinical and statistical analysis of related prognostic factors. Circulation 1994, 90:1855-1860.